Effect of Enteral Nutrition Enriched in Protein and Based on Indirect Calorimetry Measurement in Chronically Critically Ill Patients

NCT01142570 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2010-10-05

No results posted yet for this study

Summary

This is a single-center, prospective, randomized, comparative, double-blind controlled clinical study intended to establish 1) the optimal method of determining calorie requirements and 2) the optimal amount of protein supply in chronically ventilated patients.

Conditions

  • Critically Ill

Interventions

OTHER

Caloric Support (Group 1)

Four group 1-dose of caloric support will be calculated by Hariss-Benedict Formula measurement of Resting Energy Expenditure(REE).

OTHER

Caloric Support (Group 2)

For group 2- dose of caloric support will be calculated by Indirect Calorimetric measurement of Resting Energy Expenditure(REE)

DIETARY_SUPPLEMENT

Protein dose of 1.1 to 1.5 grams per kilogram weight.

Patients in the first group(Group 1A) will receive caloric support calculated by the HARRISS BENEDICT equation and protein dose of 1.1 to 1.5 grams per kilogram weight.

DIETARY_SUPPLEMENT

Protein at 1.1 grams per kilogram weight.

Patients in the second group(Group 2A) will receive caloric support as measured by indirect calorimetry and will receive protein at 1.1 grams per kilogram weight.

DIETARY_SUPPLEMENT

protein at a dose of 1.5 grams per kilogram weight.

Patients in the third group (Group 3A) will receive caloric support as measured by indirect calorimetry and will receive protein at a dose of 1.5 grams per kilogram weight.

Sponsors & Collaborators

  • Beit Rivka Hospital

    collaborator UNKNOWN
  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Gregory Papirov, MD · Beit- Rivka Hospital, Petah-Tikva, Israel

  • Pierre Singer, MD, Professor · ICU, Rabin Medical Center,Petah- Tikva, Israel

  • Ludmila Zaidenberg, MD · Beit Rivka hospital, Petah- Tikva, Israel

  • Milana Grinev, RN,Study Coordinator · ICU, Rabin Medical Center,Petah- Tikva, Israel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-09-30
Completion
2012-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01142570 on ClinicalTrials.gov